Device class
Class II
Regulation 866.3980
Total clearances
8
2020-02-10 → 2026-05-01
Definition
What is Respiratory Virus Panel Nucleic Acid Assay System
A respiratory viral panel multiplex nucleic acid assay is a qualitative in vitro diagnostic device intended to simultaneously detect and identify multiple viral nucleic acids extracted from human respiratory specimens or viral culture. The detection and identification of a specific viral nucleic acid from individuals exhibiting signs and symptoms of respiratory infection aids in the diagnosis of respiratory viral infection when used in conjunction with other clinical and laboratory findings. The device is intended for detection and identification of a combination of the following viruses: Influenza A and Influenza B, Influenza A subtype H1 and Influenza A subtype H3, Respiratory Syncytial Virus subtype A and Respiratory Syncytial Virus subtype B, Parainfluenza 1, Parainfluenza 2, and Parainfluenza 3 virus, Human Metapneumovirus, Rhinovirus, and Adenovirus.
Classification details
Medical specialty
Microbiology
Regulation number
866.3980
Trend
Clearance volume by quarter
Players
Top sponsors in this product code
Reimbursement
Likely billing codes (AI-inferred · verify with billing)
Healthcare providers using this device would typically bill under these HCPCS Level II
(alphanumeric) or CPT (5-digit) codes. Mapping inferred from device function by Claude Haiku;
official descriptions pulled from the CMS HCPCS April 2026 quarterly file where available.
Always verify with billing/coding teams before relying on these.
| Code | Type | Description | Confidence | Rationale |
| 87633 |
CPT
|
— |
High
|
Respiratory viral panel nucleic acid assay multiplex; standard code for viral panel PCR/NAA |
| 87631 |
CPT
|
— |
Medium
|
Respiratory virus antigen detection; alternative if antigen-based assay included |
Pulse
Most recent 510(k) clearances
| Date | K-number | Sponsor | Device |
| 2026-05-01 |
K254139 |
Applied BioCode, Inc.
|
BioCode® Respiratory Pathogen Panel (RPP) |
| 2024-10-02 |
K242613 |
Luminex Molecular Diagnostics, Inc.
|
NxTAG® Respiratory Pathogen Panel |
| 2023-10-10 |
K232775 |
Abbott Diagnostics Scarborough, Inc.
|
ID NOW Influenza A & B 2 |
| 2023-05-05 |
K231017 |
Hologic, Inc.
|
Panther Fusion AdV/hMPV/RV Assay |
| 2022-07-06 |
K213822 |
Roche Molecular Systems, Inc.
|
cobas Influenza A/B & RSV nucleic acid test for use on the cobas Liat System |
| 2021-02-16 |
K210234 |
Roche Molecular Systems, Inc.
|
cobas Influenza A/B & RSV Nucleic acid test for use on the cobas Liat System |
| 2020-08-22 |
K201505 |
Diasorin Molecular, LLC
|
Simplexa Flu A/B & RSV Direct Gen II, Simplexa Flu A/B & RSV Positive Control Pack |
| 2020-02-10 |
K200065 |
Roche Molecular Systems, Inc.
|
cobas Influenza A/B Nucleic acid test for use on the cobas Liat System, cobas Influenza A/B & RSV Nucleic acid test for use on the cobas Liat System, cobas Strep A Nucleic acid test for use on the cobas Liat System |